Mx1 GTPase accumulates in distinct nuclear domains and inhibits influenza A virus in cells that lack promyelocytic leukaemia protein nuclear bodies

Journal of General Virology

Volumn 85, Issue 8, 2004, Pages 2315-2326

  Engelhardt, Othmar G ^a,d   Sirma, Hüseyin ^b   Pandolfi, Pier Paolo ^c   Haller, Otto ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOPLASM PROTEIN; GUANOSINE TRIPHOSPHATASE; MYXOVIRUS RESISTANCE PROTEIN A; NUCLEAR PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN MX1; UNCLASSIFIED DRUG; VIRUS PROTEIN; ANTIVIRUS AGENT; GUANINE NUCLEOTIDE BINDING PROTEIN; MYXOVIRUS RESISTANCE PROTEINS; PML PROTEIN, MOUSE; TRANSCRIPTION FACTOR; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL NUCLEUS; GENE TRANSLOCATION; HUMAN; HUMAN CELL; INFLUENZA VIRUS A; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; VIRUS INHIBITION; VIRUS TRANSCRIPTION; WILD TYPE; ANIMAL; CHEMISTRY; GROWTH, DEVELOPMENT AND AGING; PHYSIOLOGY;

INFLUENZA A VIRUS; MURINAE;

ANIMALS; ANTIVIRAL AGENTS; CELL NUCLEUS; GTP-BINDING PROTEINS; INFLUENZA A VIRUS; MICE; NEOPLASM PROTEINS; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 4043064324     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.79795-0     Document Type: Article

References (56)

1. Accola, M. A., Huang, B., Al Masri, A. & McNiven, M. A. (2002). The antiviral dynamin family member, MxA, tubulates lipids and localizes to the smooth endoplasmic reticulum. J Biol Chem 277, 21829-21835.
2. Blondel, D., Regad, T., Poisson, N., Pavie, B., Harper, F., Pandolfi, P. P., de The, H. & Chelbi-Alix, M. K. (2002). Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies. Oncogene 21, 7957-7970.
3. Borden, K. L. (2002). Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies. Mol Cell Biol 22, 5259-5269.
4. Borden, K. L., Campbell Dwyer, E. J. & Salvato, M. S. (1998). An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm. J Virol 72, 758-766.
5. Chee, A. V., Lopez, P., Pandolfi, P. P. & Roizman, B. (2003). Promyelocytic leukemia protein mediates interferon-based antiherpes simplex virus I effects. J Virol 77, 7101-7105.
6. Chelbi-Alix, M. K., Pelicano, L., Quignon, F., Koken, M. H., Venturini, L., Stadler, M., Pavlovic, J., Degos, L. & de The, H. (1995). Induction of the PML protein by interferons in normal and APL cells. Leukemia 9, 2027-2033.
7. Chelbi-Alix, M. K., Quignon, F., Pelicano, L., Koken, M. H. & de The, H. (1998). Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J Virol 72, 1043-1051.
8. Der, S. D., Zhou, A., Williams, B. R. & Silverman, R. H. (1998). Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A 95, 15623-15628.
9. Djavani, M., Rodas, J., Lukashevich, I. S., Horejsh, D., Pandolfi, P. P., Borden, K. L. & Salvato, M. S. (2001). Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus. J Virol 75, 6204-6208.
10. Dreiding, P., Staeheli, P. & Haller, O. (1985). Interferon-induced protein Mx accumulates in nuclei of mouse cells expressing resistance to influenza virusee. Virology 140, 192-196.
11. Dull, T., Zufferey, R., Kelly, M., Mandel, R. J., Nguyen, M., Trono, D. & Naldini, L. (1998). A third-generation lentivirus vector with a conditional packaging system. J Virol 72, 8463-8471.
12. Engelhardt, O. G., Ullrich, E., Kochs, G. & Haller, O. (2001). Interferon-induced antiviral Mx1 GTPase is associated with components of the SUMO-1 system and promyelocytic leukemia protein nuclear bodies. Exp Cell Res 271, 286-295.
13. Engelhardt, O. G., Boutell, C., Orr, A., Ullrich, E., Haller, O. & Everett, R. D. (2003). The homeodomain-interacting kinase PKM (HIPK-2) modifies ND10 through both its kinase domain and a SUMO-1 interaction motif and alters the posttranslational modification of PML. Exp Cell Res 283, 36-50.
14. Everett, R. D. (2001). DNA viruses and viral proteins that interact with PML nuclear bodies. Oncogene 20, 7266-7273.
15. Flohr, F., Schneider-Schaulies, S., Haller, O. & Kochs, G. (1999). The central interactive region of human MxA GTPase is involved in GTPase activation and interaction with viral target structures. FEBS Lett 463, 24-28.
16. Garber, E. A., Hreniuk, D. L., Scheidel, L. M. & van der Ploeg, L. H. (1993). Mutations in murine Mx1: effects on localization and antiviral activity. Virology 194, 715-723.
17. Gautier, C., Mehtali, M. & Lathe, R. (1989). A ubiquitous mammalian expression vector, pHMG, based on a housekeeping gene promoter. Nucleic Acids Res 17, 8389.
18. Gongora, C., David, G., Pintard, L., Tissot, C., Hua, T. D., Dejean, A. & Mechti, N. (1997). Molecular cloning of a new interferon-induced PML nuclear body-associatcd protein. J Biol Chem 272, 19457-19463.
19. Grotzinger, T., Sternsdorf, T., Jensen, K. & Will, H. (1996). Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML). Eur J Biochem 238, 554-560.
20. Guldner, H. H., Szostecki, C., Grotzinger, T. & Will, H. (1992). IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis. J Immunol 149, 4067-4073.
21. Haller, O. & Kochs, G. (2002). Interferon-induced Mx proteins: dynamin-like GTPases with antiviral activity. Traffic 3, 710-717.
22. Haller, O., Arnheiter, H. & Lindenmann, J. (1976). Genetically determined resistance to infection by hepatotropic influenza A virus in mice: effect of immunosuppression. Infect Immun 13, 844-854.
23. Haller, O., Frese, M., Rost, D., Nuttall, P. A. & Kochs, G. (1995). Tick-borne thogoto virus infection in mice is inhibited by the orthomyxovirus resistance gene product Mx1. J Virol 69, 2596-2601.
24. Ishov, A. M., Sotnikov, A. G., Negorev, D., Vladimirova, O. V., Neff, N., Kamitani, T., Yeh, E. T., Strauss, J. F., III & Maul, G. G. (1999). PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol 147, 221-234.
25. Israel, A. (1979). Preliminary characterization of the particles from productive and abortive infections of L cells by fowl plague virus. Ann Microbiol (Paris) 130B, 85-100.
26. Kochs, G., Trost, M., Janzen, C. & Haller, O. (1998). MxA GTPase: oligomerization and GTP-dependent interaction with viral RNP target structures. Methods 15, 255-263.
27. Kochs, G., Haener, M., Aebi, U. & Haller, O. (2002). Self-assembly of human MxA GTPase into highly ordered dynamin-like oligomers. J Biol Chem 277, 14172-14176.
28. Kolb, E., Laine, E., Strehler, D. & Staeheli, P. (1992). Resistance to influenza virus infection of Mx transgenic mice expressing Mx protein under the control of two constitutive promoters. J Virol 66, 1709-1716.
29. Lavau, C., Marchio, A., Fagioli, M. & 7 other authors (1995). The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene 11, 871-876.
30. Lindenmann, J., Deuel, E., Fanconi, S. & Haller, O. (1978). Inborn resistance of mice to myxoviruses: macrophages express phenotype in vitro. J Exp Med 147, 531-540.
31. Meier, E., Fah, J., Grob, M. S., End, R., Staeheli, P. & Haller, O. (1988). A family of interferon-induced Mx-related mRNAs encodes cytoplasmic and nuclear proteins in rat cells. J Virol 62, 2386-2393.
32. Melen, K. & Julkunen, I. (1997). Nuclear cotransport mechanism of cytoplasmic human MxB protein. J Biol Chem 272, 32353-32359.
33. Melen, K., Ronni, T., Broni, B., Krug, R. M., von Bonsdorff, C. H. & Julkunen, I. (1992). Interferon-induced Mx proteins form oligomers and contain a putative leucine zipper. J Biol Chem 267, 25898-25907.
34. Nakayama, M., Yazaki, K., Kusano, A., Nagata, K., Hanai, N. & Ishihama, A. (1993). Structure of mouse Mx1 protein. Molecular assembly and GTP-dependent conformational change. J Biol Chem 268, 15033-15038.
35. Nason-Burchenal, K., Gandini, D., Botto, M., Allopenna, J., Seale, J. R., Cross, N. C., Goldman, J. M., Dmitrovsky, E. & Pandolfi, P. P. (1996). Interferon augments PML and PML/RAR alpha expression in normal myeloid and acute promyelocytic cells and cooperates with all-trans retinoic acid to induce maturation of a retinoid-resistant promyelocytic cell line. Blood 88, 3926-3936.
36. Negorev, D. & Maul, G. G. (2001). Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot. Oncogene 20, 7234-7212.
37. Piazza, F., Gurrieri, C. & Pandolfi, P. P. (2001). The theory of APL. Oncogene 20, 7216-7222.
38. Pitossi, F., Blank, A., Schroder, A., Schwarz, A., Hussi, P., Schwemmle, M., Pavlovic, J. & Staeheli, P. (1993). A functional GTP-binding motif is necessary for antiviral activity of Mx proteins. J Virol 67, 6726-6732.
39. Ponten, A., Sick, C., Weeber, M., Haller, O. & Kochs, G. (1997). Dominant-negative mutants of human MxA protein: domains in the carboxy-terminal moiety are important for oligomerization and antiviral activity. J Virol 71, 2591-2599.
40. Rasheed, Z. A., Saleem, A., Ravee, Y., Pandolfi, P. P. & Rubin, E. H. (2002). The topoisomerase 1-binding RING protein, topors, is associated with promyelocytic leukemia nuclear bodies. Exp Cell Res 277, 152-160.
41. Regad, T. & Chelbi-Alix, M. K. (2001). Role and fate Of PML nuclear bodies in response to interferon and viral infections. Oncogene 20, 7274-7286.
42. Regad, T., Saib, A., Lallemand-Breitenbach, V., Pandolfi, P. P., de The, H. & Chelbi-Alix, M. K. (2001). PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator. EMBO J 20, 3495-3505.
43. Salomoni, P. & Pandolfi, P. P. (2002). The role of PML in tumor suppression. Cell 108, 165-170.
44. Shiels, C., Islam, S. A., Vatcheva, R., Sasieni, P., Sternberg, M. J., Freemont, P. S. & Sheer, D. (2001). PML bodies associate specifically with the MHC gene cluster in interphase nuclei. J Cell Sci 114, 3705-3716.
45. Staeheli, P. & Haller, O. (1985). Interferon-induced human protein with homology to protein Mx of influenza virus-resistant mice. Mol Cell Biol 5, 2150-2153.
46. Staeheli, P., Haller, O., Boll, W., Lindenmann, J. & Weissmann, C. (1986). Mx protein: constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus. Cell 44, 147-158.
47. Staeheli, P., Grob, R., Meier, E., Sutcliffe, J. G. & Haller, O. (1988). Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation. Mol Cell Biol 8, 4518-4523.
48. Toyoda, T., Asano, Y. & Ishihama, A. (1995). Role of GTPase activity of murine Mx1 protein in nuclear localization and anti-influenza virus activity. J Gen Virol 76, 1867-1869.
49. Trost, M., Kochs, G. & Haller, O. (2000). Characterization of a novel serine/threonine kinase associated with nuclear bodies. J Biol Chem 275, 7373-7377.
50. Wang, I. F., Reddy, N. M. & Shen, C. K. (2002). Higher order arrangement of the eukaryotic nuclear bodies. Proc Natl Acad Sci U S A 99, 13583-13588.
51. Wang, J., Shiels, C., Sasieni, P., Wu, P. J., Islam, S. A., Freemont, P. S. & Sheer, D. (2004). Promyelocytic leukemia nuclear bodies associate with transcriptionally active genomic regions. J Cell Biol 164, 515-526.
52. Zhong, S., Muller, S., Ronchetti, S., Freemont, P. S., Dejean, A. & Pandolfi, P. P. (2000a). Role of SUMO-1-modified PML in nuclear body formation. Blood 95, 2748-2752.
53. Zhong, S., Salomoni, P. & Pandolfi, P. P. (2000b). The transcriptional role of PML and the nuclear body. Nat Cell Biol 2, E85-E90.
54. Zufferey, R., Dull, T., Mandel, R. J., Bukovsky, A., Quiroz, D., Naldini, L. & Trono, D. (1998). Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72, 9873-9880.
55. Zurcher, T., Pavlovic, J. & Staeheli, P. (1992a). Mechanism of human MxA protein action: variants with changed antiviral properties. EMBO J 11, 1657-1661.
56. Zurcher, T., Pavlovic, J. & Staeheli, P. (1992b). Nuclear localization of mouse Mx1 protein is necessary for inhibition of influenza virus. J Virol 66, 5059-5066.